[go: up one dir, main page]

DK0455789T3 - Fremgangsmåde til forebyggelse eller begrænsning af reperfusionsbeskadigelse - Google Patents

Fremgangsmåde til forebyggelse eller begrænsning af reperfusionsbeskadigelse

Info

Publication number
DK0455789T3
DK0455789T3 DK90917677.8T DK90917677T DK0455789T3 DK 0455789 T3 DK0455789 T3 DK 0455789T3 DK 90917677 T DK90917677 T DK 90917677T DK 0455789 T3 DK0455789 T3 DK 0455789T3
Authority
DK
Denmark
Prior art keywords
preventing
reperfusion damage
compound
limiting reperfusion
limiting
Prior art date
Application number
DK90917677.8T
Other languages
English (en)
Inventor
Herman Van Belle
Willy J C Van Laerhoven
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of DK0455789T3 publication Critical patent/DK0455789T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A61K38/166—Streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Protection Of Pipes Against Damage, Friction, And Corrosion (AREA)
  • Dicing (AREA)
  • Branch Pipes, Bends, And The Like (AREA)
  • Golf Clubs (AREA)
  • Professional, Industrial, Or Sporting Protective Garments (AREA)
  • Suspension Of Electric Lines Or Cables (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
  • Paper (AREA)
  • External Artificial Organs (AREA)
DK90917677.8T 1989-11-22 1990-11-19 Fremgangsmåde til forebyggelse eller begrænsning af reperfusionsbeskadigelse DK0455789T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44014289A 1989-11-22 1989-11-22
SG118494A SG118494G (en) 1989-11-22 1994-08-20 Method of preventing or limiting reperfusion damage

Publications (1)

Publication Number Publication Date
DK0455789T3 true DK0455789T3 (da) 1994-04-05

Family

ID=26664237

Family Applications (2)

Application Number Title Priority Date Filing Date
DK90917677.8T DK0455789T3 (da) 1989-11-22 1990-11-19 Fremgangsmåde til forebyggelse eller begrænsning af reperfusionsbeskadigelse
DK93201656T DK0577171T3 (da) 1989-11-22 1990-11-19 Anvendelse af piperazinacetamidderivater mod reperfusionsskader

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK93201656T DK0577171T3 (da) 1989-11-22 1990-11-19 Anvendelse af piperazinacetamidderivater mod reperfusionsskader

Country Status (22)

Country Link
EP (2) EP0455789B1 (da)
JP (1) JP2574585B2 (da)
KR (1) KR0165686B1 (da)
AT (2) ATE213943T1 (da)
AU (1) AU632888B2 (da)
CA (1) CA2044143C (da)
CY (1) CY1869A (da)
DE (2) DE69033926T2 (da)
DK (2) DK0455789T3 (da)
ES (2) ES2173883T3 (da)
FI (1) FI109694B (da)
HK (1) HK115095A (da)
HU (1) HU215847B (da)
IE (1) IE65121B1 (da)
IL (1) IL96390A (da)
NO (2) NO304519B1 (da)
NZ (1) NZ236168A (da)
PT (2) PT95959B (da)
RU (1) RU2093156C1 (da)
SG (1) SG118494G (da)
WO (1) WO1991007967A2 (da)
ZA (1) ZA909345B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9202266D0 (sv) * 1992-07-31 1992-07-31 Kabi Pharmacia Ab Novel piperazine carboxamides
SE9504661D0 (sv) 1995-12-22 1995-12-22 Astra Pharma Inc New compounds
RU2216549C2 (ru) * 1997-11-07 2003-11-20 Дайити Фармасьютикал Ко., Лтд. Пиперазин-циклодекстриновый комплекс и лекарственное средство, содержащее указанный комплекс
US6683100B2 (en) 1999-01-19 2004-01-27 Novartis Ag Organic compounds
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
SE9904674D0 (sv) 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE9904673D0 (sv) 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE0001209D0 (sv) 2000-04-04 2000-04-04 Astrazeneca Canada Inc Novel compounds
US6573264B1 (en) * 2000-10-23 2003-06-03 Cv Therapeutics, Inc. Heteroaryl alkyl piperazine derivatives
PT1395567E (pt) 2001-05-18 2009-03-26 Astrazeneca Ab Derivados de 4(fenil-piperazinil-metil)benzamida e sua utilização para o tratamento da ansiedade da dor ou de distúrbios gastrointestinais
SE0203300D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203302D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203303D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
US20090018351A1 (en) * 2003-11-12 2009-01-15 Dr. Reddy's Laboratories, Inc. Preparation of escitalopram
DK1781631T3 (da) 2004-08-02 2012-05-14 Astrazeneca Ab Diarylmethylpiperazinderivater, præparater dermed og anvendelser deraf
FR2946340B1 (fr) 2009-06-05 2011-06-24 Galderma Res & Dev Nouveaux n-phenyl acetamie, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant.
KR101900124B1 (ko) 2014-06-25 2018-09-18 전남대학교산학협력단 전복 박리용 조성물
KR101644299B1 (ko) 2014-07-22 2016-08-02 주식회사 엔바이로젠 오미자 및 삼채 추출물을 유효성분으로 포함하는 전복 박리용 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766125A (en) * 1981-06-23 1988-08-23 Janssen Pharmaceutica N.V. N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia
NZ223847A (en) * 1987-04-01 1989-12-21 Janssen Pharmaceutica Nv Substituted piperazine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
ES2173883T3 (es) 2002-11-01
HU9102436D0 (en) 1991-12-30
FI109694B (fi) 2002-09-30
JP2574585B2 (ja) 1997-01-22
IE904209A1 (en) 1991-05-22
NO912511L (no) 1991-08-26
DK0577171T3 (da) 2002-06-03
CA2044143C (en) 2002-11-19
HUT58709A (en) 1992-03-30
ES2053208T3 (es) 1994-07-16
FI913433A0 (fi) 1991-07-16
IL96390A (en) 1995-06-29
SG118494G (en) 1994-11-25
NO912511D0 (no) 1991-06-26
EP0455789A1 (en) 1991-11-13
DE69033926D1 (de) 2002-04-11
DE69033926T2 (de) 2002-10-24
NO311701B1 (no) 2002-01-14
NO304519B1 (no) 1999-01-04
EP0577171A2 (en) 1994-01-05
DE69007471T2 (de) 1994-06-23
DE69007471D1 (de) 1994-04-21
IL96390A0 (en) 1991-08-16
PT95959B (pt) 1998-08-31
AU632888B2 (en) 1993-01-14
AU6876391A (en) 1991-06-26
PT102145B (pt) 2002-06-28
WO1991007967A2 (en) 1991-06-13
KR920700644A (ko) 1992-08-10
ZA909345B (en) 1992-08-26
PT102145A (pt) 1999-10-29
NO982078D0 (no) 1998-05-07
CY1869A (en) 1996-04-05
KR0165686B1 (ko) 1999-01-15
ATE102831T1 (de) 1994-04-15
EP0577171A3 (en) 1994-06-29
EP0455789B1 (en) 1994-03-16
PT95959A (pt) 1991-09-13
HK115095A (en) 1995-07-21
NZ236168A (en) 1993-05-26
WO1991007967A3 (en) 1991-07-11
ATE213943T1 (de) 2002-03-15
HU215847B (hu) 1999-04-28
NO982078L (no) 1991-08-26
CA2044143A1 (en) 1991-05-23
EP0577171B1 (en) 2002-03-06
RU2093156C1 (ru) 1997-10-20
IE65121B1 (en) 1995-10-04

Similar Documents

Publication Publication Date Title
DK0455789T3 (da) Fremgangsmåde til forebyggelse eller begrænsning af reperfusionsbeskadigelse
PT96145A (pt) Processo para a preparacao de novos derivados de aminoacidos e de composicoes farmaceuticas que os contem
FI850078L (fi) N-(4-piperidinyl)-bicykliska -kondenserade 2-imidazolaminderivat.
DK0734383T3 (da) Cykliske amidderivater som neurokinin-A-antagonister
DK74691D0 (da) 4(4-(substitueret phenyl)-1-piperazinyl)phenoler og fremgangsmaade til fremstilling deraf
BR9305164A (pt) Composto, formulação farmacêutica e processo para preparar um composto
DK149852C (da) Analogifremgangsmaade til fremstilling af substituerede 3-aminosydnoniminer eller et farmakologisk acceptabelt syreadditionssalt deraf
MX9200777A (es) 4-[(2-benzotiazolil)metilamino]-alfa-[(3,4-difluorofenoxi)metil]-1-pip eridetanol.
DE68923169D1 (de) Verwendung von fluor enthaltenden Pyridoncarbonsäure-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von HIV infektionen.
DE68922605D1 (de) Verfahren zur Herstellung von (-)2-(2-(2-Aminoethoxy)ethoxy)methyl)-4-(2,3-dichlorphenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridin, und Zwischenprodukt zu dessen Herstellung.
FI920945L (fi) Menetelmä terapeuttisesti käyttökelpoisen 2,3,4,5,6,7-heksahydro-1-(4- 1-/4-(2-metoksifenyyli)piperatsinyyli/ -2-fenyylibutyryyli)-1H-atsepiinin tai sen farmaseuttisesti hyväksyttävän happoadditiosuolan valmis tamiseksi